Photosynthetic Tumor Oxygenation by Photosensitizer-Containing Cyanobacteria for Enhanced Photodynamic Therapy

Angew Chem Int Ed Engl. 2020 Jan 27;59(5):1906-1913. doi: 10.1002/anie.201912824. Epub 2019 Dec 13.

Abstract

Sustained tumor oxygenation is of critical importance during type-II photodynamic therapy (PDT), which depends on the intratumoral oxygen level for the generation of reactive oxygen species. Herein, the modification of photosynthetic cyanobacteria with the photosensitizer chlorin e6 (ce6) to form ce6-integrated photosensitive cells, termed ceCyan, is reported. Upon 660 nm laser irradiation, sustained photosynthetic O2 evolution by the cyanobacteria and the immediate generation of reactive singlet oxygen species (1 O2 ) by the integrated photosensitizer could be almost simultaneously achieved for tumor therapy using type-II PDT both in vitro and in vivo. This work contributes a conceptual while practical paradigm for biocompatible and effective PDT using hybrid microorganisms, displaying a bright future in clinical PDT by microbiotic nanomedicine.

Keywords: cyanobacteria; oxygenation; photodynamic therapy; photosensitizers; photosynthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cyanobacteria / chemistry*
  • Humans
  • Neoplasms / therapy*
  • Photochemotherapy / methods*
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use*

Substances

  • Photosensitizing Agents